Cerevel Therapeutics Hldng I shares owned by Allianz Asset Management
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Allianz Asset Management
from 13F filings
Historical chart of Allianz Asset Management investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Allianz Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.2M | 55k | 40.89 |
| 2023-12-31 | $6.1M | 144k | 42.40 |
| 2022-06-30 | $746k | 28k | 26.43 |
| 2022-03-31 | $905k | 26k | 35.00 |
| 2021-12-31 | $657k | 20k | 32.43 |